- Book Now
- OTHER AVCJ Events 2019
- Contact Us
Senior M&A experts confirmed are
Peter Adams joined Vermilion Partners as Managing Director of the Beijing office in 2011 and has over a decade of investment banking and corporate M&A experience in the U.S. and Asia. Prior to joining Vermilion, he spent six years at Siemens, based in their regional headquarters in Beijing, where he was responsible for mergers and acquisitions across Asia. His team completed transactions in China, Japan, Korea, Malaysia and Thailand, during which period Siemens China grew its revenue base from Euro4.5bn to Euro6.4bn.
Prior to joining Siemens, Peter was based in New York, where he worked in Merrill Lynch’s financial institutions group, for whom he also served in their Beijing and Tokyo offices. He subsequently joined International Technology Investment Managers (Asia), a technology venture firm, where he managed capital raising for an Asian direct investment fund; and, Enterprise Air, a software group, where he managed capital raising and mergers and acquisitions strategies; both based in New York. Peter holds a B.A. Magna Cum Laude from Yale University in East Asian Studies and speaks fluent Mandarin and some Japanese.
Peter is based in Beijing and has lived there since 2006. He also lived in Beijing in 1985 and 1995, and in Taiwan in 1986-1987 and 1989-1990
Cliff Chau joined HOPU Investments in 2012 and serves as CFO, Co-COO and Partner in charge of healthcare investments. Cliff has over 20 years of experience in international financial industry with in-depth financial advisory and management experience in both the U.S. and China. Besides his CFO and Co-COO duties, he focuses on building a HOPU healthcare ecosystem and investing in biotech, medtech and healthcare services companies.
Cliff brings a wealth of experience in investments, risk management, operations and sales & marketing to his approach to healthcare industry. His current portfolio companies include Ambrx Inc., a biopharmaceutical company headquartered in San Diego, Mevion Medical Systems, a proton therapy system company headquartered in Massachusetts and I-Mab Biopharma, a China-based global player in innovative biologics and he sits on the boards of Ambrx and Mevion. In the early stage of his career, Cliff was responsible for the sales and marketing of clinical and laboratory products of Beckman Instruments, Bio-Rad and Merck in China.
Prior to joining HOPU, Cliff was the Managing Director and Head of Finance Department of China Investments Corporation (CIC). He was a member of CIC’s risk management committee and an observer of investment committee. He also represented CIC sitting on the boards of CITIC Capital and China Jianyin Investment Limited. Before CIC, Cliff was a Partner of KPMG’s Transaction Services Practice, where he advised numerous cross-border transactions and was deeply involved with assisting companies to implement their China strategies. He worked at KPMG’s Beijing office and Los Angeles office.
Cliff also sits on the boards of Advisory Committee for the Quantitative Finance Program of The Chinese University of Hong Kong (CUHK), Sinopec Marketing Company, and The China Tea Company.
Cliff holds an MBA from State University of New York, a BSc. in Biochemistry from CUHK and a C.P.A. State of California.
With more than 30 years of work experience, Ms. Chen has been engaged in engineering design, project management, business development and investment management. She currently serves as the senior executive of flagship subsidiary of Baowu Group and is responsible for corporate business planning and equity investment. Familiar with the M&A process, she has rich experience in participating of large-scale state-owned enterprise in market-based M&A. Given the fact that she personally led several overseas investment and M&A projects, successfully implemented three overseas and multiple domestic M&A transactions, and participated in post-investment management, therefore Ms. Chen owns more thorough understanding and comprehension over it.
Mr. Chen provides overall leadership to InterChina’s M&A advisory, corporate finance, and investment advisory practice. He is a member of the firm’s Management Committee
Mr. Chen has over 20 years cross border mergers & acquisitions, corporate finance, and strategic planning experience in the infrastructure/logistics, consumer, technology, manufacturing, retail, and financial service sectors. He led and advised over 200 M&A and divestiture transactions, with over 70 successful completions in the North America, Asia Pacific, and European regions. Transaction size range from $50M to $8 billion
Prior to InterChina, Barry worked for Price Waterhouse and UPS in the corporate finance and corporate development function. He also has long time collaboration with all leading investment banking firms including Goldman Sachs, Morgan Stanley, Merrill Lynch, Credit Suisse, UBS, and JP Morgan. He has extensive experience in deal origination, evaluating cross border acquisitions in a strategic context, and understands the complexity in structuring, valuing, and integrating the acquired companies. He is an experienced negotiator, and has extensive senior level contacts and origination capacity.
Herry is Founding Partner of Lightspeed China Partners (LCP), a leading China-focused early-stage venture capital firm with investments in mobile Internet, consumer services, and enterprise IT. LCP manages around $1B assets through three USD funds and one RMB fund. Previously, Herry was an Executive Director with Lightspeed Venture Partners (LSVP), and joined the Shanghai office in 2008. Headquarted in the Silicon Valley, LSVP manages over $4B assets and has offices globally.
Herry’s investments at LCP and LSVP include Tujia, Full Truck Alliance (Yun Man Man), Fang Duo Duo, Xing Bian Li, Trusted Doctors, Ifchange, PPDai (NYSE:PPDF), LianLuo Interactive (SHE: 002280) and MediaV (acquired by Qihoo), etc.
Herry was on the 2018 Top 100 VC in China by China Venture. Herry was on the 2017 Top 50 VC Investors in China by Jiemian, Toutiao and Golden Rolls. Herry was on the Cyzone.cn's list of “China Top 40 Investors under 40" for year 2014, 2015, 2016, 2017 and 2018.
Previously, Herry was a consultant with McKinsey & Company, assisting clients in hi-tech, telecom, media, automotive, and energy industries. He worked closely with board members at Fortune 500 and domestic clients. Additionally, he interacted closely with various domestic government bodies and on NGO projects.
Prior to McKinsey, Herry worked as an engineer at Microsoft China. He is the founder of a McKinsey alumni investors' group, ExMcK@Investment, which has more than 200 VC and PE members across China.
Mr. Lee joined BPEA in 2007. Mr. Lee leads buyout investments as part of the Greater China Investment Team. Prior to joining the firm, Mr. Lee was an Associate with private equity firm Tullis-Dickerson based in Greenwich, Connecticut. He began his career in the investment banking division of Goldman Sachs.
Mr. Lee graduated magna cum laude with a B.A. in Economics and East Asian Studies from Columbia University and an M.B.A. from Stanford Graduate School of Business. He is fluent in English, Mandarin and Taiwanese.
Stanford Lin is Vice President & Head of Strategy & Business Development for Nestlé Greater China Region, based in Beijing.
Stanford has nearly 20 years of experience in consumer-facing businesses. Prior to joining Nestlé in 2017, Stanford was Head of Products at Visa China, responsible for Visa’s consumer and commercial card solutions. He also served as chief operating officer for Visa China.
Prior to joining Visa, Stanford worked at Walmart China in a variety of executive roles, including Head of Financial Services and Head of Strategy & Innovation.
Before joining Walmart, Stanford was a management consultant at McKinsey & Company. Early in his career, Stanford practiced corporate and securities law at Davis Polk & Wardwell and served as in-house counsel at Reuters.
Born in the U.S., Stanford holds a BA from Duke University, a JD from Harvard Law School and an MBA from MIT Sloan.
Speaker bio coming soon
Raghu Narain brings over 20 years of experience in investment banking, corporate finance and economic policy advisory. Currently, Mr. Narain is Head of Investment Banking for Natixis, APAC with the responsibility to deliver M&A, Acquisition Financing, Strategic Equity, and DCM solutions. Prior to Natixis, Mr. Narain was the Head of Sector Advisory and Global Industrials Group in RBS Asia. In his career, he has undertaken over 100 transactions by financing and advising US$100+ billion in completed deals for global companies. He has advised major global entities including Eurazeo, Sanyuan, Tsinghua, Continental Airlines, Fosun, GVK, Lafarge, MISC, MGM, Reliance, Shanghai Electric, Vedanta and UPS. Prior to working in Asia, he was at Bank of America in New York where he was a Director responsible for M&A and capital raising activities for the Global Transportation and Logistics Group. Mr. Narain began his investment banking career with Salomon Smith Barney / Citigroup in New York.
Mr. Narain has also worked at Bridgewater Associates as an Investment Associate and in the field of development finance at the Harvard Institute for International Development (HIID). He completed his Masters degree from Harvard University. He holds MPA, MBA and BA degrees from the United States. He is a member of the International Honor Society of Beta Gamma Sigma. He has often been highlighted in leading industry media CNBC Squawk Box, Institutional Investors, The Asset, IFR, Marine Money, Drillers and Dealers Digest and The Daily Deal for his achievements in the field of financial services.
Henriette Peucker works out of the Berlin and Brussels offices in the Corporate Affairs & Public Strategies Practice of Hering Schuppener/Finsbury. She focuses on advising companies in strategic stakeholder communications, especially on how to position themselves and advocate their interests in the political sphere. Among her clients are various global B2B and B2C companies that are invested in Europe and rely on handling complex regulatory matters. These includes merger analysis, state aid, trade disputes and cartels – the result of competition procedures by both the EU Commission and national competition authorities. Henriette joined the firm in 2010 from Deutsche Boerse Group where she was Head of European Public Affairs. Prior, she worked in investment banking in London and in public affairs in Paris and Brussels.
LLM, with over 17-year multinational legal affairs management experiences, Victor used to work in a Hong Kong red-chip mobile communication company, a multi-national cosmetics company, and a world-class retail conglomerate. His extensive experience has equipped him with rich business knowledge of various industries, a sharp sense of different industry sectors and legal practice experiences. Victor has worked at Henkel for over 10 years, during which he has led his team handled numerous and complicated legal affairs and projects in the areas of international & domestic restructuring, divesture, mergers & acquisitions, labor, anti-trust, tax, customs, dispute resolution, government affairs, compliance and corporate governance. Victor’s performances has won him a high recognition from the Headquarters’ management, and he was elected as one of the Top General Counsel in 2015 by Asia Legal Business of Thomson Reuters. Victor’s current practices and study interests concentrate on the legal systems of foreign direct investment, anti-trust, mergers & acquisitions, tax law and corporate law. Victor was also invited from time to time by professional forums as the guest speaker on the above mentioned areas.
Simon Tsang is a managing director in the Valuation Advisory Services practice, and is based in the firm’s Shanghai office. Simon has more than 18 years of valuation, private equity investment and tax advisory experience in China and Hong Kong.
Simon is experienced in providing valuation advice and deliverables for private equity clients, for merger and acquisition transactions, and for financial reporting and initial public offerings (IPO) purposes. Simon has extensive experience in valuation, including purchase price allocation analysis, intangible asset valuation, financial derivatives valuation, financial modeling, business and equity interest valuation for acquisitions, divestitures, joint ventures, financing, restructuring, IPO, tax, go-private transactions and financial reporting.
Simon has advised clients in a wide variety of industries, including consumer products, life sciences and healthcare, manufacturing, technology and telecommunication, media and real estate. He has particular expertise in private equity portfolio valuation and has previously worked for a private equity firm, where he was responsible for deal execution and investment analysis. He has delivered presentations and training on valuation topics at various professional events. Before joining Duff & Phelps, Simon was a Partner in Deloitte Financial Advisory Services in China. Earlier in his career, he worked for a private equity firm as well as an international appraisal firm.
Gian-Marc Widmer is Director and Head of International M&A at CITIC Securities. He joined the firm in 2014 and is focusing on sourcing and execution of cross-border transactions involving Chinese investors/targets.
Based in Beijing, he has more than 15 years experience in M&A, restructuring and corporate development with a track record of more than US$15bn of transactions executed in Europe, Asia, North+South America.
Mr. Widmer has been a buy-side financial adviser to clients including SOEs such as CRRC, TravelSky, China Duty Free, Guangdong Airport Authority, CNNC, Huadian, Oriental Pearl Group etc; to Chinese private clients including SanPower, Suning, Shanghai Raas, By-Health, Robam, ctrip etc and has advised foreign corporate clients and PE funds such as Diageo, Carlsberg, AB InBev, Publicis, BASF, Allianz, IFC, Capvis, Charterhouse Capital etc on China-related transactions including exits, restructurings etc.
Mr. Widmer has previously worked at Lazard in London and New York focusing on transactions including M&A and debt restructuring as well as at Altira Group in their renewable energy fund as head of the China investment team.
Mr. Widmer has been based in China since 2005, holds an MBA from INSEAD and speaks Chinese.
Eric Xin is the Senior Managing Director and Managing Partner of CITIC Capital China Private Equity. Previously, Mr. Xin was a management consultant with McKinsey & Co. in Shanghai and Washington, D.C. Mr. Xin has an MBA from Harvard Business School, with Honors, and a BA from Peking University.
Xiaolin is a Director in JD’s Strategic Investment team, and is responsible for developing and implementing the group strategy of JD via investments and M&A.
Prior to JD, Xiaolin co-founded and held the title of Head of Business Development at YouJieYouHuan, a China P2P start up fintech company, now called Meili Finance, based in Beijing.
Xiaolin started her career as an investment banker at Merrill Lynch in 2009, and was an associate in Deutsche Bank’s Technology, Media, and Telecommunications team between 2011-2014. She was born and raised in China and received a full scholarship to study in Singapore and the US, graduating with a First-Honor Bachelor Degree (Major in Quantitative Finance) from the National University of Singapore.